Head Topics

DONANEMAB News

Latest News On DONANEMAB

Can Alzheimer's Drugs Extend Independence? New Study Estimates

Can Alzheimer's Drugs Extend Independence? New Study Estimates

2/13/2025 6:29 PM
China Approves Eli Lilly's Donanemab for Early Alzheimer's

China Approves Eli Lilly's Donanemab for Early Alzheimer's

12/17/2024 7:25 PM
AFA responds to approval of Alzheimer’s Drug by FDA Advisory Committee

AFA responds to approval of Alzheimer’s Drug by FDA Advisory Committee

6/12/2024 3:25 PM
Alzheimer's drug that can slow disease gets backing from FDA advisers

Alzheimer's drug that can slow disease gets backing from FDA advisers

6/11/2024 7:15 AM
Alzheimer’s Disease Drug Donanemab Gets Unanimous Backing From FDA Expert Panel

Alzheimer’s Disease Drug Donanemab Gets Unanimous Backing From FDA Expert Panel

6/11/2024 6:52 AM
Alzheimer's drug that can slow disease gets backing from FDA advisers

Alzheimer's drug that can slow disease gets backing from FDA advisers

6/11/2024 5:57 AM
Alzheimer's drug that can slow disease gets backing from FDA advisers

Alzheimer's drug that can slow disease gets backing from FDA advisers

6/11/2024 5:16 AM
Eli Lilly’s Alzheimer’s Drug Donanemab Is Being Considered For FDA Approval—Here’s What To Know

Eli Lilly’s Alzheimer’s Drug Donanemab Is Being Considered For FDA Approval—Here’s What To Know

6/10/2024 5:02 AM
Eli Lilly’s Alzheimer’s Drug Donanemab Is Being Considered For FDA Approval—Here’s What To Know

Eli Lilly’s Alzheimer’s Drug Donanemab Is Being Considered For FDA Approval—Here’s What To Know

6/10/2024 5:02 AM
Medicare Says It Expects To Spend $3.5 Billion In 2025 On Alzheimer’s Drug Leqembi, But This Is Unlikely

Medicare Says It Expects To Spend $3.5 Billion In 2025 On Alzheimer’s Drug Leqembi, But This Is Unlikely

5/3/2024 7:16 AM


Render Time: 2025-02-15 09:29:25